Detalles de la búsqueda
1.
Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity.
Haemophilia;
30(1): 140-150, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38058226
2.
ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome.
Pediatr Int;
66(1): e15773, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38863279
3.
Coagulant potentials of emicizumab in the plasmas from infant and toddler patients with hemophilia A.
Pediatr Blood Cancer;
70(10): e30590, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37467119
4.
Size-Dependent Geometrical Structures of Platinum Oxide Cluster Cations Studied by Ion Mobility-Mass Spectrometry.
J Phys Chem A;
127(16): 3570-3576, 2023 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058573
5.
Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis.
Eur J Haematol;
109(1): 100-108, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35430749
6.
Comprehensive coagulation and fibrinolytic potential in the acute phase of pediatric patients with idiopathic nephrotic syndrome evaluated by whole blood-based rotational thromboelastometry.
Pediatr Nephrol;
37(7): 1605-1614, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34997323
7.
Coagulation potential in pediatric patients with immunoglobulin A nephropathy.
Pediatr Int;
64(1): e15042, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34699659
8.
Protein C system in preterm babies with chronic lung disease: Prospective study.
Pediatr Int;
64(1): e15221, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35912452
9.
A microchip flow-chamber assay screens congenital primary hemostasis disorders.
Pediatr Int;
63(2): 160-167, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32640065
10.
Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis-treated haemophilia A patients with inhibitors.
Br J Haematol;
190(5): 727-735, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162680
11.
Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
Haemophilia;
25(3): e174-e179, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30866149
12.
Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot® ) evaluated by global coagulation assay in patients with acquired haemophilia A.
Haemophilia;
30(1): 249-252, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38031253
13.
Intra-articular haemorrhage caused by reduced recovery of PEGylated recombinant factor VIII due to an anti-PEG antibody developed after mRNA-1273 SARS-CoV-2 vaccination in haemophilia A.
Haemophilia;
29(3): 935-938, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37040322
14.
In vitro evaluation of global coagulation potentials in the co-presence of plasma-derived factors Viia/X products (Byclot® ) and emicizumab in patients with haemophilia A and inhibitors and acquired haemophilia A: A pilot study.
Haemophilia;
28(5): e149-e152, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35947585
15.
The role of proteolytic cleavage at Arg336 and Arg372 of the A1 domain in factor VIIa/tissue factor-catalyzed reactions of B domain-deleted factor VIII.
Biochim Biophys Acta Gen Subj;
1868(1): 130501, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37925034
16.
The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential.
Blood Adv;
2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38820442
17.
Additional Factor X Enhances Emicizumab-Driven Coagulation Function in Patients with Hemophilia A and Hemophilia A Mice.
Thromb Haemost;
2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38677278
18.
NXT007-mediated hemostatic potential is suppressed by activated protein C-catalyzed inactivation of activated factor V.
Res Pract Thromb Haemost;
8(1): 102271, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38115953
19.
Emicizumab-mediated hemostatic function assessed by thrombin generation assay in an in vitro model of factor VIII-depleted thrombophilia plasma.
Int J Hematol;
119(2): 109-118, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38112996
20.
Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential.
Blood Adv;
7(8): 1436-1445, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36322904